Lutikizumab (anti-IL1a&IL1b), 白细胞介素-1α抑制剂

    应用:
  • Animal Model
  • ELISA
  • Flow Cytometry
  • Functional Assay
功能和特点
  • 宿主种属: 人(Human)
  • 种属反应性: 人(Human), 小鼠(Mouse), 食蟹猴(Cynomolgus monkey)
  • 亚型: Human IgG1
  • 偶联: Unconjugated
有货

库存信息

关闭

库存信息

关闭

库存信息

关闭

库存信息

关闭
货号 (SKU) 包装规格 是否现货 价格 数量
Ab175588-100μg
100μg 现货 Stock Image
Ab175588-1mg
1mg 现货 Stock Image
Ab175588-5mg
5mg 现货 Stock Image
Ab175588-10mg
10mg 期货 Stock Image

基本信息

产品名称 Lutikizumab (anti-IL1a&IL1b), 白细胞介素-1α抑制剂
别名 鲁吉珠单抗 | 鲁吉珠单抗 | 鲁替珠单抗(抗 IL1a 和 IL1b)
英文别名 BAF antibody | FAF antibody | Hematopoietin 1 antibody | Hematopoietin-1 antibody | IL 1 alpha antibody | IL 1A antibody | IL-1 alpha antibody | Il-1a antibody | IL1 ALPHA antibody | IL1 antibody | IL1A antibody | IL1A_HUMAN antibody | IL1F1 antibody | In
规格或纯度 无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, 无动物源, ≥90%(SDS-PAGE&SEC-HPLC), 见COA
宿主种属 人(Human)
特异性 IL1A & IL1B
种属反应性 人(Human),小鼠(Mouse),食蟹猴(Cynomolgus monkey)
偶联 Unconjugated
作用类型 抑制剂
作用机制 白细胞介素-1α抑制剂

产品属性

克隆类型 重组抗体
Format Whole IgG
亚型 Human IgG1
轻链亚型 kappa
SDS-PAGE 196.8 kDa
纯化方法 Protein A purified
防腐剂 No
浓度 见COA
储存温度 -80℃储存,避免反复冻融
运输条件 超低温冰袋运输
稳定性与储存 在 -80℃ 下保存 24 个月。收货后建议分装。避免冷冻/解冻循环。
CAS编号和信息 1791411-57-8
分子类型 抗体

图片

Lutikizumab (anti-IL1a&IL1b) (Ab175588) - ELISA
Immobilized Recombinant Human IL-1 alpha protein (rp156178) at 1.0 μg/mL can bind Lutikizumab (anti-IL1a&IL1b) (Ab175588) with the EC50 of 38.93 ng/mL.

Lutikizumab (anti-IL1a&IL1b) (Ab175588) - SEC
The purity of Lutikizumab (anti-IL1a&IL1b) (Ab175588) is more than 95% verified by HPLC.

安全和危险性(GHS)

质量标准

质检证书(CoA,COO,BSE/TSE 和分析图谱)

C of A & Other Certificates(BSE/TSE, COO):
输入批号以搜索分析图谱:

通过匹配包装上的批号来查找并下载产品的 COA,每批产品都进行了严格的验证,您可放心使用!

找到3个结果

批号(Lot Number) 证书类型 日期 货号
ZJ24F1113367 分析证书 24-11-05 Ab175588
ZJ24F1113366 分析证书 24-11-05 Ab175588
ZJ24F1113365 分析证书 24-11-05 Ab175588

参考文献

1. Dayer JM, Graham R, Russell G, Krane SM.  (1977)  Collagenase production by rheumatoid synovial cells: stimulation by a human lymphocyte factor..  Science,  195  (4274): (181-3).  [PMID:188134]
2. DiGiammarino E, Ghayur T, Liu J.  (2012)  Design and generation of DVD-Ig™ molecules for dual-specific targeting..  Methods Mol Biol,  899  (145-56).  [PMID:22735951]
3. Lacy SE, Wu C, Ambrosi DJ, Hsieh CM, Bose S, Miller R, Conlon DM, Tarcsa E, Chari R, Ghayur T et al..  (2015)  Generation and characterization of ABT-981, a dual variable domain immunoglobulin (DVD-Ig(TM)) molecule that specifically and potently neutralizes both IL-1α and IL-1β..  MAbs,  (3): (605-19).  [PMID:25764208]
4. Wang SX, Abramson SB, Attur M, Karsdal MA, Preston RA, Lozada CJ, Kosloski MP, Hong F, Jiang P, Saltarelli MJ et al..  (2017)  Safety, tolerability, and pharmacodynamics of an anti-interleukin-1α/β dual variable domain immunoglobulin in patients with osteoarthritis of the knee: a randomized phase 1 study..  Osteoarthr Cartil,  25  (12): (1952-1961).  [PMID:28964890]
5. Goldring MB, Birkhead J, Sandell LJ, Kimura T, Krane SM.  (1988)  Interleukin 1 suppresses expression of cartilage-specific types II and IX collagens and increases types I and III collagens in human chondrocytes..  J Clin Invest,  82  (6): (2026-37).  [PMID:3264290]
6. Goldring MB, Krane SM.  (1987)  Modulation by recombinant interleukin 1 of synthesis of types I and III collagens and associated procollagen mRNA levels in cultured human cells..  J Biol Chem,  262  (34): (16724-9).  [PMID:3500170]
7. Dayer JM, Roelke MS, Krane SM.  (1984)  Effects of prostaglandin E2, indomethacin, trifluoperazine and drugs affecting the cytoskeleton on collagenase production by cultured adherent rheumatoid synovial cells..  Biochem Pharmacol,  33  (18): (2893-9).  [PMID:6089839]
8. McGuire-Goldring MB, Meats JE, Wood DD, Ihrie EJ, Ebsworth NM, Russell RG.  (1984)  In vitro activation of human chondrocytes and synoviocytes by a human interleukin-1-like factor..  Arthritis Rheum,  27  (6): (654-62).  [PMID:6610426]

溶液计算器